Pharmaffiliates

What Pharmaffiliates does

Pharmaffiliates is a privately held India-headquartered research organization founded in 2001 that operates two integrated businesses: a pharmaceutical reference standards catalog operation and a full-service Contract Research, Development, and Manufacturing Organization (CRDMO). Its reference standards business maintains over 10,000 ready in-stock impurity standards and a 300,000+ compound catalog covering pharmaceutical, food and beverage, agro-chemical, environmental, and green chemistry applications, including deuterated and stable isotope-labeled compounds. Its CRDMO business delivers custom synthesis of small and large molecules, analytical method development and validation, stability studies per ICH guidelines, structure elucidation using advanced instrumentation (UPLC, 1D/2D NMR, LC-MS, ICP-MS), impurity profiling, polymorphism studies, nano-lipoidal novel drug delivery systems, regulatory consulting, DMF and ANDA dossier preparation, GMP/GLP training, and third-party audits for EMEA compliance. The company holds USFDA-inspected status and commits to an ISO/IEC 17025:2017-aligned quality system.

Name

Pharmaffiliates

Legal name

Pharmaffiliates Private Limited

Website

https://pharmaffiliates.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

251–500 employees

Short description

Pharmaffiliates is an India-based pharmaceutical research organization founded in 2001 that manufactures impurity reference standards and provides CRDMO services including custom synthesis, analytical testing, and regulatory submissions to pharma, biotech, and research customers worldwide.

Ownership category

akta.pro rank

Product category

Pharmaceutical Reference Standards

NAICS

Pharmaceutical Preparation Manufacturing (325412), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Services-Commercial Physical & Biological Research (8731), Pharmaceutical Preparations (2834), Chemicals & Allied Products (2800)

akta.pro primary industry

Impurity / Reference Standard Synthesis & Characterization (HLAGAHAG)

akta.pro secondary industries

Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM), Generic ANDA/Regulatory Affairs & Submissions (HLAIABAJ), Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC)

Keywords

• Pharmaceutical reference standards
• Custom synthesis services
• Analytical method development
• Contract research manufacturing
• Impurity profiling services

Headquarters

HQ city

Haryana

HQ country

India

HQ region

Asia

Offices6 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Supply Chain, Marketing or Sales

Revenue model

1. Pharmaceutical Reference Standards Sales: Sale of pharmaceutical impurity standards, reference standards, metabolites, stable isotopes, and related compounds to pharmaceutical companies, API manufacturers, and research institutions. Products are sold in catalog quantities with custom synthesis available.
2. Contract Research Services: Custom synthesis services for small and large molecules, analytical method development and validation, stability studies, and regulatory consulting including DMF/ANDA submissions. Charged on project or FTE (Full-time Equivalent) basis.
3. Analytical Testing Services: Wet lab analysis, instrumentation analysis, and specialized testing services for pharmaceutical products. Services include structure elucidation, purity assessment, and regulatory-compliant testing.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Pharmaffiliates manufactures pharmaceutical impurity reference standards (over 10,000 in-stock items, 300,000+ catalog compounds) and provides Contract Research, Development, and Manufacturing Organization (CRDMO) services including custom synthesis of small and large molecules, deuterated compounds, analytical method development and validation, stability studies, structure elucidation, impurity profiling, regulatory dossier/DMF/ANDA submission support, and GMP/GLP training and third-party audits for pharma, biotech, API manufacturers, CROs, and academic research customers globally.

Product overview

Pharmaffiliates is a research-driven CRDMO (Contract Research, Development, and Manufacturing Organization) and impurity standard manufacturer based in India. The company operates two primary business segments: a comprehensive portfolio of pharmaceutical, food, environmental, and agrochemical reference standards, and full-service contract research capabilities spanning drug development from early research through regulatory submission. The core product offering includes over 10,000 ready-in-stock impurities and 300,000+ compounds in catalog, supported by integrated services including custom synthesis (small and large molecules), analytical method development and validation, stability studies, structure elucidation, regulatory consulting, DMF/ANDA submissions, and GMP/GLP training. The company maintains global operations with offices in India, UK, Canada, and Lithuania, and is USFDA inspected.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Reference Standards Certified reference standards for pharmaceutical quality control and testing, including impurities, metabolites, intermediates, glucuronides, nitrosamines, peptides, stable isotopes, psychotropic substance standards, food and beverage standards, agro-chemical standards, environmental standards, green chemistry standards, and fine chemicals, sold to API manufacturers, finished-dose pharma companies, biotech firms, CROs, and research institutions.
• Ultrachrome Chromatography Columns Proprietary branded chromatography columns for analytical separations, sold alongside the reference standards catalog to pharmaceutical and analytical laboratory customers.
• Deuterated and Isotope-Labeled Compounds Catalog and custom-synthesized deuterium, 13C, 15N, 31P, 19F, and 17O isotope-labeled compounds used for reaction mechanism studies, metabolic pathway analysis, and as mass spectroscopy internal standards.
• CRDMO Services Integrated Contract Research, Development, and Manufacturing Organization services encompassing the full drug development lifecycle from early research through commercialization, including custom synthesis, analytical development, regulatory submission support, and manufacturing, provided under one roof to pharmaceutical and biotech customers.
• Custom Synthesis (Small and Large Molecules) Custom synthesis of small molecules (APIs, key intermediates, chiral standards, metabolites, glucuronides, stable isotopes from milligrams to grams) and large/complex biomolecules requiring multi-step synthesis, delivered to pharmaceutical and biotech clients.
• Novel Drug Delivery Systems Development of nano lipoidal carrier systems using bio-friendly biomaterials such as phospholipids for applications in dermatology, cosmetics, and nutraceuticals, provided to pharmaceutical and personal care clients.
• Impurity Profiling Identification, isolation, and characterization of pharmaceutical impurities for safety evaluation and regulatory compliance, delivered to API manufacturers and finished-dose pharmaceutical companies.
• Polymorphism Studies Study of crystalline forms using vibrational spectroscopies (IR and Raman) to detect and characterize different polymorphic forms of drug substances for pharmaceutical development clients.
• Analytical Method Services (Development, Validation, Transfer) Analytical method development for APIs and formulations testing for specificity, linearity, accuracy, precision, and robustness; validation of analytical procedures for API, drug products, and containers per regulatory requirements; and formal transfer of validated methods between laboratories.
• Stability Studies and Evaluation Stability testing including R&D preliminary studies, QC stability studies, comparator studies, and photostability evaluations per ICH Q1A–Q1F guidelines, delivered to pharmaceutical development and quality clients.
• Structure Elucidation and Evaluation Structural characterization using UPLC, chiral chromatography, and 1D/2D NMR for intermediates, impurities, degradation products, and metabolites, delivered to pharmaceutical and biotech customers.
• Regulatory Consulting Expert consulting for global regulatory issues with a focus on flexibility, multidisciplinary projects, and relations with health authorities, provided to pharmaceutical, biotech, and API manufacturer clients.
• Dossier Preparation (CTD Format) Preparation of regulatory dossiers and ANDAs in Common Technical Document (CTD) format for global submissions, delivered to pharmaceutical manufacturers and biotech firms.
• DMF and ANDA Submissions Preparation of Drug Master File (DMF) and Active Substance Master File (ASMF) with CMC regulatory documentation for FDA, EMA, and worldwide submissions, delivered to API manufacturers and finished-dose pharmaceutical companies.
• Analytical Testing Services (Wet Lab, Instrumentation, Specialized) Classical wet chemistry techniques (loss on drying, limit tests, identification, TLC, sulphated ash, viscosity) and instrument-based analytical testing using UV, GC-MS, HPLC, UPLC, FTIR, ICP, and ICP-MS, plus unique specialized testing for complex requirements, delivered to pharmaceutical, biotech, and research customers.
• GMP/GLP Training Programs Expert-led training programs including lectures, workshops, and videos covering GMP and GLP topics, delivered to pharmaceutical professionals across the industry.
• Third-Party Audits Independent third-party auditing services in India and neighboring countries per EMEA requirements, delivered to pharmaceutical manufacturers seeking inspection readiness.
• FTE-Based Research Projects Full-time equivalent (FTE) based project services with dedicated research teams headed by Ph.D. scientists, providing outsourced pharmaceutical R&D capacity to clients.

Quantifiable outcome

• Supports regulatory compliance in 90+ countries
• +2 more outcomes

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators7 records

Recent moves4 records

Expansion highlights5 records

Direct peers

• Clearsynth Labs: Clearsynth is an India-based manufacturer of impurity reference standards, stable-isotope-labeled compounds, and CRDMO services — directly competing with Pharmaffiliates in catalog SKU overlap and a near-identical go-to-market targeting global generic pharma and CRO customers.
• Toronto Research Chemicals: TRC is a leading global supplier of impurity reference standards and deuterated compounds serving pharmaceutical and analytical customers — the closest catalog-direct competitor to Pharmaffiliates' reference standards and isotope-labeled portfolios.
• LGC Standards: LGC is one of the largest global reference-material producers (pharmaceutical impurities, CRMs, calibration standards) and operates adjacent CRMO capabilities — a direct competitor in impurity standards with overlap into analytical services.
• TCI Chemicals: TCI manufactures and globally distributes organic chemicals, reference standards, and stable-isotope-labeled reagents — directly comparable in catalog breadth, regulatory-grade quality, and pharma customer base.

Broad incumbents

• Sigma-Aldrich (MilliporeSigma / Merck KGaA): MilliporeSigma/Supelco is the dominant global reference-standards supplier covering impurities, analytical standards, CRMs, and chromatography alongside a vast life-sciences portfolio — the broad incumbent whose catalog Pharmaffiliates competes against.
• Syngene International: Syngene is an Indian-headquartered integrated CRDMO offering discovery, development, and manufacturing services to global pharma and biotech — comparable in geography, service breadth, and target buyer but at a meaningfully larger scale.
• Piramal Pharma Solutions: Piramal operates a global CDMO with API and drug-product manufacturing plus analytical/regulatory services — a fellow Indian-rooted CRDMO that overlaps with Pharmaffiliates on the development-and-submission workstream, but at materially larger scale.
• Eurofins Scientific: Eurofins is a global contract testing, reference-material, and analytical services group — comparable to Pharmaffiliates' analytical testing and reference-standards offerings as part of a much broader life-sciences testing portfolio.

Emerging players

• Aragen Life Sciences (GVK Biosciences): Aragen is an India-based CRDMO with discovery, development, and CMC services — overlapping with Pharmaffiliates on impurity profiling, analytical, and regulatory services for pharma R&D customers.
• Vivimed Labs: Vivimed manufactures specialty chemicals and pharma intermediates including reference standards and intermediates — comparable product overlap to Pharmaffiliates' catalog and custom-synthesis business from a fellow Indian specialty-chemicals platform.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/pharmapkl
• Facebookfacebook.com/pharmaffiliates

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmaffiliates